Patient Safety Organizations: Delisting for Cause for Leadership Triad, 70561 [2013-28279]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 228 / Tuesday, November 26, 2013 / Notices
requirements of section 3.108(c)(2)(i) of
the Patient Safety Rule regarding
notification of providers that have
reported to the PSO. In addition,
according to section 3.108(c)(2)(ii) of the
Patient Safety Rule regarding
disposition of PSWP, the PSO has 90
days from the effective date of delisting
and revocation to complete the
disposition of PSWP that is currently in
the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
Dated: November 14, 2013.
Richard Kronick,
Director.
[FR Doc. 2013–28284 Filed 11–25–13; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations: Delisting
for Cause for Leadership Triad
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
AGENCY:
AHRQ has delisted
Leadership Triad due to its failure to
correct a deficiency. The Patient Safety
and Quality Improvement Act of 2005
(Patient Safety Act), Public Law 109–41,
42 U.S.C. 299b–21—b–26, authorizes
the listing of Patient Safety
Organizations (PSOs), which are entities
or component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
and Quality Improvement Final Rule
(Patient Safety Rule) to implement the
Patient Safety Act. AHRQ administers
the provisions of the Patient Safety Act
and Patient Safety Rule relating to the
listing and operation of PSOs.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on October 4, 2013.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:04 Nov 25, 2013
Jkt 232001
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email: pso@
AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, provides for
the formation of PSOs, which collect,
aggregate, and analyze confidential
information regarding the quality and
safety of health care delivery. The
Patient Safety Rule, 42 CFR Part 3,
authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule.
Section 3.108(d) of the Patient Safety
Rule requires AHRQ to provide public
notice when it removes an organization
from the list of federally approved
PSOs.
In response to a Notice of Proposed
Revocation and Delisting sent by AHRQ
pursuant to 42 CFR 3.108(a)(3)(iii)(C),
Leadership Triad stated that it did not
meet the requirement that, within 24
months of initial listing, the PSO must
have two bona fide contracts with
different providers for the purpose of
receiving and reviewing patient safety
work product. Accordingly, pursuant to
42 CFR 3.108(a)(5), the notice of
proposed revocation was affirmed and
AHRQ revoked the listing of Leadership
Triad, PSO number P0117, a component
entity of Triad Health Care LLC,
effective at 12:00 Midnight ET (2400) on
October 4, 2013.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
Dated: November 14, 2013.
Richard Kronick,
Director.
[FR Doc. 2013–28279 Filed 11–25–13; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–0770]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
70561
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to LeRoy Richardson,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to omb@
cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Proposed Project
National HIV Behavioral Surveillance
System (NHBS)—(0920–0770,
Expiration 05/31/2014)—Extension—
Center for HIV, Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The purpose of this data collection is
to monitor behaviors of persons at high
risk for infection that are related to
Human Immunodeficiency Virus (HIV)
transmission and prevention in the
United States. The primary objectives of
the NHBS system are to obtain data from
samples of persons at risk to: (a)
Describe the prevalence and trends in
risk behaviors; (b) describe the
prevalence of and trends in HIV testing
and HIV infection; (c) describe the
prevalence of and trends in use of HIV
prevention services; (d) identify met and
unmet needs for HIV prevention
services in order to inform health
departments, community based
organizations, community planning
groups and other stakeholders.
By describing and monitoring the HIV
risk behaviors, HIV seroprevalence and
incidence, and HIV prevention
experiences of persons at highest risk
for HIV infection, NHBS provides an
important data source for evaluating
progress towards national public health
E:\FR\FM\26NON1.SGM
26NON1
]]>Agencies
[Federal Register Volume 78, Number 228 (Tuesday, November 26, 2013)]
[Notices]
[Page 70561]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-28279]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Delisting for Cause for Leadership
Triad
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: AHRQ has delisted Leadership Triad due to its failure to
correct a deficiency. The Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act), Public Law 109-41, 42 U.S.C. 299b-21--b-26,
authorizes the listing of Patient Safety Organizations (PSOs), which
are entities or component organizations whose mission and primary
activity is to conduct activities to improve patient safety and the
quality of health care delivery. HHS issued the Patient Safety and
Quality Improvement Final Rule (Patient Safety Rule) to implement the
Patient Safety Act. AHRQ administers the provisions of the Patient
Safety Act and Patient Safety Rule relating to the listing and
operation of PSOs.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12:00
Midnight ET (2400) on October 4, 2013.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD
20850; Telephone (toll free): (866) 403-3697; Telephone (local): (301)
427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130;
Email: pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, provides for the formation of PSOs, which
collect, aggregate, and analyze confidential information regarding the
quality and safety of health care delivery. The Patient Safety Rule, 42
CFR Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it meets the statutory and
regulatory requirements for listing. A PSO can be ``delisted'' by the
Secretary if it is found to no longer meet the requirements of the
Patient Safety Act and Patient Safety Rule. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of federally approved PSOs.
In response to a Notice of Proposed Revocation and Delisting sent
by AHRQ pursuant to 42 CFR 3.108(a)(3)(iii)(C), Leadership Triad stated
that it did not meet the requirement that, within 24 months of initial
listing, the PSO must have two bona fide contracts with different
providers for the purpose of receiving and reviewing patient safety
work product. Accordingly, pursuant to 42 CFR 3.108(a)(5), the notice
of proposed revocation was affirmed and AHRQ revoked the listing of
Leadership Triad, PSO number P0117, a component entity of Triad Health
Care LLC, effective at 12:00 Midnight ET (2400) on October 4, 2013.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.AHRQ.gov/.
Dated: November 14, 2013.
Richard Kronick,
Director.
[FR Doc. 2013-28279 Filed 11-25-13; 8:45 am]
BILLING CODE 4160-90-P
